Browse Category

SGX:KEP News 19 January 2026 - 23 January 2026

Keppel Limited stock rises on 25-year Bifrost cable deal; investors eye Feb 5 results

Keppel Limited stock rises on 25-year Bifrost cable deal; investors eye Feb 5 results

SINGAPORE, Jan 23, 2026, 15:08 SGT — regular session Keppel Ltd shares climbed 1.1% to S$11.01 by 2:50 p.m. SGT on Friday, following the announcement of a 25-year contract linked to its Bifrost trans-Pacific subsea cable. The stock kicked off at S$11.00 and fluctuated between S$10.97 and S$11.06, with roughly 2.1 million shares traded. (StockAnalysis) This move is significant because…
Keppel stock price hovers near 52-week high as Feb 5 results near

Keppel stock price hovers near 52-week high as Feb 5 results near

SINGAPORE, January 19, 2026, 15:44 SGT — Regular session Keppel Ltd shares nudged higher in Singapore afternoon trade Monday, staying close to recent peaks. The stock gained 0.18% to S$10.92 by 3:20 p.m. local time, fluctuating between S$10.80 and S$10.94 earlier. (StockAnalysis) The timing is set: Keppel and its listed REITs will unveil their second-half and full-year 2025 results ahead…

Stock Market Today

  • Treace Medical Concepts (TMCI) Stock Shows 81% Upside Amid Profitability Concerns
    January 23, 2026, 8:12 AM EST. Treace Medical Concepts, Inc. (NASDAQ: TMCI) trades near its 52-week low at $2.69, despite a market cap of $171.4 million and a potential upside of 81% based on average analyst targets of $4.87. The healthcare device maker, known for its Lapiplasty 3D bunion correction system, shows 11.4% revenue growth but faces profitability challenges with a negative forward P/E of -3.96 and EPS of -0.80. Operational efficiency is weak, highlighted by a -51.63% return on equity and negative free cash flow of $9.2 million. Technical indicators reveal bearish momentum amid mixed analyst ratings, underscoring the stock's speculative nature. Investors should weigh growth prospects against financial risks carefully.
Go toTop